Doctors reported at the American Society of Clinical Oncology annual meeting that scaling back treatment for ovarian, esophageal, and Hodgkin lymphoma cancers can make life easier for patients without compromising outcomes. This trend towards doing less, including less surgery, chemotherapy, or radiation, is part of a long-term study to help patients live longer and feel better. Studies showed that less intensive treatment can be just as effective and reduce complications for patients. Researchers are reevaluating the need for aggressive treatments and focusing on optimizing cancer care with improved drugs. This shift towards less intensive treatment was discussed at a recent conference in Chicago.
Source link